(FUL) H Fuller - Overview
Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NYSE (USA) | Market Cap: 3.164m USD | Total Return: 7.1% in 12m
Avg Turnover: 23.6M
EPS Trend: 16.2%
Qual. Beats: 0
Rev. Trend: -72.2%
Qual. Beats: 0
Warnings
Choppy Below Avwap Earnings
Tailwinds
Confidence
H.B. Fuller Company is a global manufacturer of specialty chemical products, primarily focusing on industrial adhesives, sealants, and coatings. The company organizes its operations into three distinct segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions. These business units serve diverse end markets ranging from medical and electronics to aerospace and commercial roofing.
The specialty chemicals sector is characterized by high customer switching costs due to the critical role adhesives play in product performance and manufacturing integrity. H.B. Fuller utilizes a business model centered on technical formulation, often integrating its products directly into the automated assembly lines of its global clientele.
For more detailed insights into the company’s fundamental health, you may find further data on ValueRay useful. Founded in 1887, the company maintains a broad geographical footprint with direct sales and distribution networks across North America, Europe, and the Asia Pacific region.
- Raw material cost fluctuations impact gross margins across specialty chemical segments
- Strategic acquisitions drive inorganic growth and expansion into high-margin engineering adhesives
- Global manufacturing activity levels dictate demand for industrial and packaging adhesive solutions
- Mortgage rates and construction volume influence sales of building and roofing products
- Energy transition and electronics innovation accelerate demand for high-performance specialty materials
| Net Income: 159.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.31 > 1.0 |
| NWC/Revenue: 17.64% < 20% (prev 16.90%; Δ 0.74% < -1%) |
| CFO/TA 0.06 > 3% & CFO 312.4m > Net Income 159.8m |
| Net Debt (2.03b) to EBITDA (571.1m): 3.55 < 3 |
| Current Ratio: 1.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.5m) vs 12m ago -0.92% < -2% |
| Gross Margin: 31.98% > 18% (prev 0.30%; Δ 3.17k% > 0.5%) |
| Asset Turnover: 67.89% > 50% (prev 71.50%; Δ -3.61% > 0%) |
| Interest Coverage Ratio: 2.90 > 6 (EBITDA TTM 571.1m / Interest Expense TTM 134.2m) |
| A: 0.12 (Total Current Assets 1.28b - Total Current Liabilities 665.9m) / Total Assets 5.22b |
| B: 0.39 (Retained Earnings 2.03b / Total Assets 5.22b) |
| C: 0.08 (EBIT TTM 389.0m / Avg Total Assets 5.09b) |
| D: 0.56 (Book Value of Equity 1.76b / Total Liabilities 3.15b) |
| Altman-Z'' = 3.13 = A |
| DSRI: 1.04 (Receivables 532.2m/525.5m, Revenue 3.46b/3.55b) |
| GMI: 0.94 (GM 31.98% / 29.94%) |
| AQI: 0.98 (AQ_t 0.57 / AQ_t-1 0.59) |
| SGI: 0.97 (Revenue 3.46b / 3.55b) |
| TATA: -0.03 (NI 159.8m - CFO 312.4m) / TA 5.22b) |
| Beneish M = -3.11 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 56.37 with a total of 992,275 shares traded.
Over the past week, the price has changed by -0.48%,
over one month by -7.94%,
over three months by -11.65% and
over the past year by +7.05%.
H Fuller has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold FUL.
- StrongBuy: 2
- Buy: 0
- Hold: 3
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 70.4 | 24.9% |
P/E Forward = 12.7877
P/S = 0.9154
P/B = 1.6159
P/EG = 2.2026
Revenue TTM = 3.46b USD
EBIT TTM = 389.0m USD
EBITDA TTM = 571.1m USD
Long Term Debt = 2.08b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.14b USD (from shortLongTermDebtTotal, last quarter) + Leases 59.1m
Net Debt = 2.03b USD (calculated: Debt 2.14b - CCE 107.9m)
Enterprise Value = 5.19b USD (3.16b + Debt 2.14b - CCE 107.9m)
Interest Coverage Ratio = 2.90 (Ebit TTM 389.0m / Interest Expense TTM 134.2m)
EV/FCF = 35.69x (Enterprise Value 5.19b / FCF TTM 145.4m)
FCF Yield = 2.80% (FCF TTM 145.4m / Enterprise Value 5.19b)
FCF Margin = 4.21% (FCF TTM 145.4m / Revenue TTM 3.46b)
Net Margin = 4.62% (Net Income TTM 159.8m / Revenue TTM 3.46b)
Gross Margin = 31.98% ((Revenue TTM 3.46b - Cost of Revenue TTM 2.35b) / Revenue TTM)
Gross Margin QoQ = 31.26% (prev 32.45%)
Tobins Q-Ratio = 0.99 (Enterprise Value 5.19b / Total Assets 5.22b)
Interest Expense / Debt = 6.28% (Interest Expense 134.2m / Debt 2.14b)
Taxrate = 26.07% (7.42m / 28.5m)
NOPAT = 287.6m (EBIT 389.0m * (1 - 26.07%))
Current Ratio = 1.92 (Total Current Assets 1.28b / Total Current Liabilities 665.9m)
Debt / Equity = 1.03 (Debt 2.14b / totalStockholderEquity, last quarter 2.07b)
Debt / EBITDA = 3.55 (Net Debt 2.03b / EBITDA 571.1m)
Debt / FCF = 13.94 (Net Debt 2.03b / FCF TTM 145.4m)
Total Stockholder Equity = 1.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.14% (Net Income 159.8m / Total Assets 5.22b)
RoE = 8.09% (Net Income TTM 159.8m / Total Stockholder Equity 1.98b)
RoCE = 9.60% (EBIT 389.0m / Capital Employed (Equity 1.98b + L.T.Debt 2.08b))
RoIC = 6.47% (NOPAT 287.6m / Invested Capital 4.45b)
WACC = 7.34% (E(3.16b)/V(5.30b) * Re(9.16%) + D(2.14b)/V(5.30b) * Rd(6.28%) * (1-Tc(0.26)))
Discount Rate = 9.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -33.33 | Cagr: -0.51%
[DCF] Terminal Value 77.97% ; FCFF base≈116.6m ; Y1≈133.6m ; Y5≈196.6m
[DCF] Fair Price = 17.10 (EV 2.96b - Net Debt 2.03b = Equity 932.0m / Shares 54.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 16.24 | EPS CAGR: 1.44% | SUE: 0.14 | # QB: 0
Revenue Correlation: -72.24 | Revenue CAGR: -0.95% | SUE: -0.04 | # QB: 0
EPS current Quarter (2026-05-31): EPS=1.38 | Chg30d=+5.83% | Revisions=+64% | Analysts=7
EPS next Quarter (2026-08-31): EPS=1.40 | Chg30d=+4.91% | Revisions=+45% | Analysts=7
EPS current Year (2026-11-30): EPS=4.72 | Chg30d=+4.34% | Revisions=+64% | GrowthEPS=+11.2% | GrowthRev=+3.9%
EPS next Year (2027-11-30): EPS=5.14 | Chg30d=+1.98% | Revisions=+27% | GrowthEPS=+9.0% | GrowthRev=+4.0%
[Analyst] Revisions Ratio: +64%